- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02025257
Effects of Exercise in Patients With Coronary Artery Disease Aged 80 Years or Older
April 10, 2022 updated by: Maria Bäck, Sahlgrenska University Hospital, Sweden
Effects of Exercise in Patients With Coronary Artery Disease Aged 80 Years or Older - a Randomized Controlled Trial
The purpose of this study is to investigate the effects of exercise for patients with coronary artery disease (CAD) aged 80 years and older, with special reference to maximum aerobic capacity, muscle endurance, physical functioning, level of physical activity, health related quality of life, anxiety, depression and endothelial function, compared to a control group.
Study Overview
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Select A State…
-
Gothenburg, Select A State…, Sweden, 41345
- Department of physiotherapy, Sahlgrenska University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
80 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of acute coronary artery disease
- Aged 80 years or older
Exclusion Criteria:
- Inability to understand or speak the Swedish language
- Serious physical or psychological disease interfering with participation in an exercise intervention
- Patients are already exercising three times or more/week
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise
Individually prescribed hospital based exercise in group two times a week, home-based exercise once a week.
The exercise intervention consists of interval based aerobic exercise on a bicycle ergometer 30 minutes with intensity level at 13-17 at Borg scale, resistance exercises and balance exercises
|
Individually prescribed hospital based exercise in group two times a week, home-based exercise once a week.
The exercise intervention consists of interval based aerobic exercise on a bicycle ergometer 30 minutes with intensity level at 13-17 at Borg scale, resistance exercises and balance exercises
|
|
No Intervention: Control
Patients are asked to live as usual.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in maximum aerobic capacity
Time Frame: At baseline and after 4 months
|
A maximum exercise test on an electronically braked cycle ergometer, with watts as marker of maximum aerobic capacity.
|
At baseline and after 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in level of physical activity
Time Frame: At baseline and after 4 months
|
Level of physical activity will be measured by an accelerometer and an activity diary
|
At baseline and after 4 months
|
|
Change in muscular endurance
Time Frame: At baseline and after 4 months
|
Will be measured by three clinical endurance tests including unilateral isotonic heel lift, unilateral isotonic shoulder flexion, bilateral isometric shoulder abduction
|
At baseline and after 4 months
|
|
Change in physical functioning
Time Frame: At baseline and after 4 months
|
Including tests of balance: short physical performance battery, one leg standing, timed up and go, and the activities specific balance confidence scale.
|
At baseline and after 4 months
|
|
Change in health related quality of life
Time Frame: At baselline and after 4 months
|
measured by a self-rated health questionnaire
|
At baselline and after 4 months
|
|
Change in anxiety and depression
Time Frame: At baseline and after 4 months
|
measured by the hospital anxiety and depression scale
|
At baseline and after 4 months
|
|
Change in endothelial function
Time Frame: At baseline and after 4 months
|
Evaluated with non-invasive ultrasound
|
At baseline and after 4 months
|
|
Change in transthoracic evaluation of resting coronary flow velocity
Time Frame: At baseline and after 4 months
|
At baseline and after 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Maria Bäck, PhD, Department of Physiotherapy, Sahlgrenska University Hospital, Gothenburg, Sweden
- Study Chair: Per Albertsson, PhD, Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2013
Primary Completion (Actual)
May 1, 2019
Study Completion (Actual)
April 1, 2022
Study Registration Dates
First Submitted
October 21, 2013
First Submitted That Met QC Criteria
December 27, 2013
First Posted (Estimate)
January 1, 2014
Study Record Updates
Last Update Posted (Actual)
April 15, 2022
Last Update Submitted That Met QC Criteria
April 10, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 462-13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.